NAPHTHOL, QUINOLINE AND ISOQUINOLINE-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR

Details for Australian Patent Application No. 2003251828 (hide)

Owner JANSSEN PHARMACEUTICA N.V.

Inventors DAX, Scott, L.; JETTER, Michele; MCDONNELL, Mark; MCNALLY, James, J.; YOUNGMAN, Mark; CODD, Ellen

Pub. Number AU-A-2003251828

PCT Number PCT/US03/21518

PCT Pub. Number WO2004/007459

Priority 60/395,728 12.07.02 US; 60/395,951 15.07.02 US

Filing date 10 July 2003

Wipo publication date 2 February 2004

International Classifications

C07D 215/00 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/395,728 12.07.02 US; 60/395,951 15.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003251828

21 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251829-Method to inhibit ischemia and reperfusion injury

2003251827-BUSINESS SERVICE FOR A MULTITIER COMPUTE INFRASTRUCTURE